Gilgamesh Pharmaceuticals is a pharmaceutical company that is developing psychedelic and related drugs as medicines. It is a "discovery stage" company and is focused on developing new chemical entities. From Wikipedia
The purchase underscores AbbVie’s bid to build a psychiatry portfolio on Phase 2 momentum.
